BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $928 | +25.7% | 24,460 | +52.0% | 0.63% | +28.2% |
| Q2 2023 | $738 | +10.5% | 16,090 | -1.7% | 0.49% | +5.6% |
| Q1 2023 | $668 | -20.6% | 16,365 | -0.3% | 0.47% | -21.2% |
| Q4 2022 | $841 | -99.9% | 16,415 | -1.4% | 0.59% | -8.3% |
| Q3 2022 | $901,000 | -16.5% | 16,640 | -0.4% | 0.65% | -7.7% |
| Q2 2022 | $1,079,000 | -17.1% | 16,715 | 0.0% | 0.70% | +8.0% |
| Q1 2022 | $1,301,000 | -9.6% | 16,715 | 0.0% | 0.65% | -2.3% |
| Q4 2021 | $1,439,000 | +6.7% | 16,715 | 0.0% | 0.66% | -11.1% |
| Q3 2021 | $1,349,000 | -1.3% | 16,715 | -1.3% | 0.75% | +0.4% |
| Q2 2021 | $1,367,000 | -4.6% | 16,940 | 0.0% | 0.74% | -10.0% |
| Q1 2021 | $1,433,000 | +5.1% | 16,940 | 0.0% | 0.83% | -3.8% |
| Q4 2020 | $1,363,000 | -0.1% | 16,940 | +0.1% | 0.86% | -13.6% |
| Q3 2020 | $1,364,000 | -6.6% | 16,915 | 0.0% | 1.00% | -14.4% |
| Q2 2020 | $1,460,000 | +6.0% | 16,915 | 0.0% | 1.16% | -7.0% |
| Q1 2020 | $1,377,000 | -3.6% | 16,915 | -0.7% | 1.25% | +39.2% |
| Q4 2019 | $1,428,000 | -4.6% | 17,040 | -0.2% | 0.90% | -9.5% |
| Q3 2019 | $1,497,000 | +14.1% | 17,075 | +6.9% | 0.99% | +15.1% |
| Q2 2019 | $1,312,000 | +0.6% | 15,975 | -0.2% | 0.86% | -12.6% |
| Q1 2019 | $1,304,000 | +23.5% | 16,000 | 0.0% | 0.99% | 0.0% |
| Q4 2018 | $1,056,000 | -16.7% | 16,000 | -2.4% | 0.99% | +9.0% |
| Q3 2018 | $1,268,000 | +4.4% | 16,400 | 0.0% | 0.90% | +5.5% |
| Q2 2018 | $1,214,000 | +12.2% | 16,400 | -1.2% | 0.86% | +3.9% |
| Q1 2018 | $1,082,000 | -8.4% | 16,600 | -8.9% | 0.83% | -8.1% |
| Q4 2017 | $1,181,000 | -14.2% | 18,225 | -16.7% | 0.90% | -19.9% |
| Q3 2017 | $1,376,000 | +2.5% | 21,875 | -1.1% | 1.12% | +3.6% |
| Q2 2017 | $1,343,000 | +11.3% | 22,125 | -4.7% | 1.08% | +6.2% |
| Q1 2017 | $1,207,000 | – | 23,225 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |